A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Talimogene laherparepvec (T-VEC) demonstrates efficacy in cutaneous BCC, enhancing resectability and altering immune cell ...

A recent study has shown that low-dose Cold Atmospheric Plasma (CAP) treatment could ... attention for its ability to selectively target tumor cells without harming surrounding healthy tissue.

The findings showcase a promising approach to bone healing and tumor control. The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells ...